Back in March 2022, Momodou Sabally’s application to contest as the Busumbala parliamentarian for the UDP was disqualified by an IEC returning officer based on his Janneh Commission ban.

This lost report captures the victim center and the National Human Rights Commission's condemnation of police brutality that followed and UDP leader Darboe’s condemnation of the IEC’s decision.

Sabally vowed to defiantly oppose the Barrow government but eventually succumbed to joining the NPP after the government rescinded his Janneh Commission ban from public office.

More in this report.

This publication, first released in March 2022, examines victims’ concerns over the Truth, Reconciliation and Reparations Commission’s (TRRC) recommendation to grant amnesty to Sana Sabally, who is widely regarded as a victim-perpetrator due to both the human rights abuses he admitted committing and the violations he suffered.

Published before the government’s decision to reject the TRRC’s amnesty recommendation for Sabally, the article explores the complex and nuanced question of how victim-perpetrators should be treated within transitional justice processes.

Read more in this previously lost article.

In September 2017, months after President Adama Barrow took office, an Israeli company, International Medical Services (IMS), presented plans to build a $220 million state-of-the-art hospital aimed at turning The Gambia into a medical tourism hub.

Our investigation examined the background of the IMS delegation and the risks associated with medical tourism. While the industry has potential benefits, global health bodies including the WHO and the Royal Society of Medicine warn it can fuel organ trafficking, citing the Philippines as a cautionary example.

This revived report from Gainako’s lost publications revisits those concerns and their relevance today.

The Gambia’s Finance Minister, Hon. Mambury Njie, informed members of the National Assembly’s Special Committee that the government received one billion dalasis in its accounts on 20th April 2020. The Minister explained that the “very soft loan from the IMF has now landed in our account. It’s a facility that they [IMF] normally provide. It’s about one billion dalasis.” More in this feature report.

The Gambia’s Medicines Control Agency shut down one of The Gambia’s prominent pharmaceutical companies Innovarx Global Health on 2nd February 2024.

The Acute Kidney Injury court case where 19 bereaved parents are seeking redress from the Gambia Government was adjourned to the end of January 2024 to allow for Indian company Maiden Pharmaceuticals to be served.

After months of sitting on the Acute Kidney Injury Investigation Report, the Ministry of Health finally published the report which culminated in the firing of the Medicines Control Agency Executive Director and the Deputy Executive Director last Friday 21st July 2023. However, they are not the only MCA Staff exposed in the report for serious conflict of interest.

The parents of 19 children who died from Acute Kidney Injury have filed a law suit against Maiden Pharmaceuticals, Atlantic Pharmaceuticals, the Medicines Control Agency, the Ministry of Health and the Attorney General on 30th June 2023.

The Gambia’s Justice Minister informed Parliament that the Government is currently pursuing diplomatic channels with the Indian Government to pursue legal action against the Indian Company responsible for manufacturing tainted medicines which took the lives of more than 73 children in The Gambia from mid-2022 to early 2023.

Has President Adama Barrow met his National Development Plan’s target to reduce the unemployment rate?